SEER 📈 Seer - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US81578P1066
SEER: Nanoparticles, Consumables, Automation, Instrumentation, Software
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Web URL: https://seer.bio
Additional Sources for SEER Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SEER Stock Overview
Market Cap in USD | 147m |
Sector | Healthcare |
Industry | Biotechnology |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception | 2020-12-04 |
SEER Stock Ratings
Growth 5y | -74.8% |
Fundamental | -44.8% |
Dividend | - |
Rel. Strength Industry | 1139 |
Analysts | 3.67/5 |
Fair Price Momentum | 1.59 USD |
Fair Price DCF | - |
SEER Dividends
No Dividends PaidSEER Growth Ratios
Growth Correlation 3m | 83.9% |
Growth Correlation 12m | 37.4% |
Growth Correlation 5y | -95.1% |
CAGR 5y | -54.53% |
CAGR/Mean DD 5y | -0.66 |
Sharpe Ratio 12m | 0.63 |
Alpha | -29.32 |
Beta | 2.41 |
Volatility | 46.42% |
Current Volume | 218.7k |
Average Volume 20d | 212.2k |
What is the price of SEER stocks?
As of December 21, 2024, the stock is trading at USD 2.31 with a total of 218,668 shares traded.
Over the past week, the price has changed by -5.69%, over one month by +1.75%, over three months by +31.82% and over the past year by +28.89%.
As of December 21, 2024, the stock is trading at USD 2.31 with a total of 218,668 shares traded.
Over the past week, the price has changed by -5.69%, over one month by +1.75%, over three months by +31.82% and over the past year by +28.89%.
Is Seer a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Seer (NASDAQ:SEER) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.78 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SEER as of December 2024 is 1.59. This means that SEER is currently overvalued and has a potential downside of -31.17%.
Probably not. Based on ValueRay Fundamental Analyses, Seer (NASDAQ:SEER) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.78 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SEER as of December 2024 is 1.59. This means that SEER is currently overvalued and has a potential downside of -31.17%.
Is SEER a buy, sell or hold?
Seer has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold SEER.
Seer has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold SEER.
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for SEER stock price target?
According to ValueRays Forecast Model, SEER Seer will be worth about 1.8 in December 2025. The stock is currently trading at 2.31. This means that the stock has a potential downside of -21.21%.
According to ValueRays Forecast Model, SEER Seer will be worth about 1.8 in December 2025. The stock is currently trading at 2.31. This means that the stock has a potential downside of -21.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 3 | 29.9% |
Analysts Target Price | 7.5 | 224.7% |
ValueRay Target Price | 1.8 | -21.2% |